These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 34315958)

  • 1. Non-pharmaceutical interventions to reduce COVID-19 transmission in the UK: a rapid mapping review and interactive evidence gap map.
    Duval D; Evans B; Sanders A; Hill J; Simbo A; Kavoi T; Lyell I; Simmons Z; Qureshi M; Pearce-Smith N; Arevalo CR; Beck CR; Bindra R; Oliver I
    J Public Health (Oxf); 2024 May; 46(2):e279-e293. PubMed ID: 38426578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost of implementing the COVID-19 shielding policy in Wales.
    Sewell B; Farr A; Akbari A; Carson-Stevens A; Dale J; Edwards A; Evans BA; John A; Torabi F; Jolles S; Kingston M; Lyons J; Lyons RA; Porter A; Watkins A; Williams V; Snooks H
    BMC Public Health; 2023 Nov; 23(1):2342. PubMed ID: 38008730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.
    Porter A; Akbari A; Carson-Stevens A; Dale J; Dixon L; Edwards A; Evans B; Griffiths L; John A; Jolles S; Kingston MR; Lyons R; Morgan J; Sewell B; Whiffen A; Williams VA; Snooks H
    BMJ Open; 2023 Aug; 13(8):e073464. PubMed ID: 37541747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.
    Evans BA; Akbari A; Bailey R; Bethell L; Bufton S; Carson-Stevens A; Dixon L; Edwards A; John A; Jolles S; Kingston MR; Lyons J; Lyons R; Porter A; Sewell B; Thornton CA; Watkins A; Whiffen T; Snooks H
    BMJ Open; 2022 Sep; 12(9):e059813. PubMed ID: 36691218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of severe COVID-19 infection in persons with diabetes during the first and second waves in Denmark: A nationwide cohort study.
    Stidsen JV; Green A; Rosengaard L; Højlund K
    Front Endocrinol (Lausanne); 2022; 13():1025699. PubMed ID: 36303877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of SARS-CoV-2 infection among patients with common variable immunodeficiency and a matched control group: A Danish nationwide cohort study.
    Katzenstein TL; Rasmussen LD; Drabe CH; Larsen CS; Hansen AE; Stærkind M; Knudsen LS; Hansen CH; Obel N
    Front Immunol; 2022; 13():994253. PubMed ID: 36211430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from past pandemics: a systematic review of evidence-based, cost-effective interventions to suppress COVID-19.
    Juneau CE; Pueyo T; Bell M; Gee G; Collazzo P; Potvin L
    Syst Rev; 2022 May; 11(1):90. PubMed ID: 35550674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    Strongman H; Carreira H; De Stavola BL; Bhaskaran K; Leon DA
    PLoS Med; 2022 Jan; 19(1):e1003870. PubMed ID: 34990450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of COVID-19 in shielded and nursing care home patients: a cohort study in general practice.
    Wingfield D; Taghavi Azar Sharabiani M; Majeed A; Molokhia M
    BJGP Open; 2021; 5(6):. PubMed ID: 34446435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study.
    Bachtiger P; Adamson A; Maclean WA; Kelshiker MA; Quint JK; Peters NS
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30460. PubMed ID: 34298499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids for the treatment of COVID-19.
    Griesel M; Wagner C; Mikolajewska A; Stegemann M; Fichtner F; Metzendorf MI; Nair AA; Daniel J; Fischer AL; Skoetz N
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD015125. PubMed ID: 35262185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of COVID-19 outcomes among shielded and non-shielded populations.
    Jani BD; Ho FK; Lowe DJ; Traynor JP; MacBride-Stewart SP; Mark PB; Mair FS; Pell JP
    Sci Rep; 2021 Jul; 11(1):15278. PubMed ID: 34315958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 May; 218():12-20. PubMed ID: 36933354
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.